
Thomas Sweeney Heard
Examiner (ID: 8001, Phone: (571)272-2064 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675 |
| Total Applications | 1286 |
| Issued Applications | 710 |
| Pending Applications | 90 |
| Abandoned Applications | 491 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12247537
[patent_doc_number] => 09920304
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-20
[patent_title] => 'Peptide capable of silica deposition and use thereof'
[patent_app_type] => utility
[patent_app_number] => 15/194712
[patent_app_country] => US
[patent_app_date] => 2016-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 22
[patent_no_of_words] => 12216
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15194712
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/194712 | Peptide capable of silica deposition and use thereof | Jun 27, 2016 | Issued |
Array
(
[id] => 12832045
[patent_doc_number] => 20180169187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF MALNUTRITION
[patent_app_type] => utility
[patent_app_number] => 15/738215
[patent_app_country] => US
[patent_app_date] => 2016-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15738215
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/738215 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MALNUTRITION | Jun 23, 2016 | Abandoned |
Array
(
[id] => 11335621
[patent_doc_number] => 20160361375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'INHIBITORS OF HEPATITIS C VIRUS'
[patent_app_type] => utility
[patent_app_number] => 15/185273
[patent_app_country] => US
[patent_app_date] => 2016-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 108477
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15185273
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/185273 | Inhibitors of hepatitis C virus | Jun 16, 2016 | Issued |
Array
(
[id] => 17133763
[patent_doc_number] => 11135299
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Chemoselective modification of a carrier protein with a strained alkyne-labeled cargo agent
[patent_app_type] => utility
[patent_app_number] => 15/576226
[patent_app_country] => US
[patent_app_date] => 2016-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11485
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15576226
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/576226 | Chemoselective modification of a carrier protein with a strained alkyne-labeled cargo agent | Jun 15, 2016 | Issued |
Array
(
[id] => 11604071
[patent_doc_number] => 20170121372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'NOVEL DEPSIPEPTIDE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/183031
[patent_app_country] => US
[patent_app_date] => 2016-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20871
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15183031
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/183031 | Methods for producing a depsipeptide | Jun 14, 2016 | Issued |
Array
(
[id] => 11082297
[patent_doc_number] => 20160279261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'PEPTIDOMIMETIC COMPOUNDS AND ANTIBODY-DRUG CONJUGATES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/182429
[patent_app_country] => US
[patent_app_date] => 2016-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 103720
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15182429
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/182429 | Peptidomimetic compounds and antibody-drug conjugates thereof | Jun 13, 2016 | Issued |
Array
(
[id] => 12506718
[patent_doc_number] => 09999681
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-19
[patent_title] => Peptidomimetic compounds and antibody-drug conjugates thereof
[patent_app_type] => utility
[patent_app_number] => 15/181825
[patent_app_country] => US
[patent_app_date] => 2016-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 24250
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15181825
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/181825 | Peptidomimetic compounds and antibody-drug conjugates thereof | Jun 13, 2016 | Issued |
Array
(
[id] => 11083667
[patent_doc_number] => 20160280632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'GAMMA AMINO ACID BUILDING BLOCKS'
[patent_app_type] => utility
[patent_app_number] => 15/174306
[patent_app_country] => US
[patent_app_date] => 2016-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 35442
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15174306
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/174306 | Gamma amino acid building blocks | Jun 5, 2016 | Issued |
Array
(
[id] => 11310273
[patent_doc_number] => 20160346383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'Ezrin-Derived Peptides and Pharmaceutical Compositions Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/170362
[patent_app_country] => US
[patent_app_date] => 2016-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9728
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15170362
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/170362 | Ezrin-derived peptides and pharmaceutical compositions thereof | May 31, 2016 | Issued |
Array
(
[id] => 11076052
[patent_doc_number] => 20160273016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'METHOD OF PRODUCING FR901228'
[patent_app_type] => utility
[patent_app_number] => 15/166524
[patent_app_country] => US
[patent_app_date] => 2016-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3299
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15166524
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/166524 | METHOD OF PRODUCING FR901228 | May 26, 2016 | Abandoned |
Array
(
[id] => 16183534
[patent_doc_number] => 10716827
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-21
[patent_title] => Compositions and methods for enhancing peptide stability against protease digestion
[patent_app_type] => utility
[patent_app_number] => 15/575501
[patent_app_country] => US
[patent_app_date] => 2016-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10882
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15575501
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/575501 | Compositions and methods for enhancing peptide stability against protease digestion | May 19, 2016 | Issued |
Array
(
[id] => 11421333
[patent_doc_number] => 20170029478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'High Molecular Weight, Post-Translationally Modified Protein Brushes'
[patent_app_type] => utility
[patent_app_number] => 15/155933
[patent_app_country] => US
[patent_app_date] => 2016-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 12098
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15155933
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/155933 | High molecular weight, post-translationally modified protein brushes | May 15, 2016 | Issued |
Array
(
[id] => 11074101
[patent_doc_number] => 20160271065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'LYOPHILIZED PREPARATIONS OF MELPHALAN FLUFENAMIDE'
[patent_app_type] => utility
[patent_app_number] => 15/149975
[patent_app_country] => US
[patent_app_date] => 2016-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9499
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15149975
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/149975 | Lyophilized preparations of melphalan flufenamide | May 8, 2016 | Issued |
Array
(
[id] => 11046170
[patent_doc_number] => 20160243128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'POLYCYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/150018
[patent_app_country] => US
[patent_app_date] => 2016-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13648
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15150018
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/150018 | POLYCYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | May 8, 2016 | Abandoned |
Array
(
[id] => 11450344
[patent_doc_number] => 09573977
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-21
[patent_title] => 'Method for preventing neoplastic transformation by inhibition of retinoblastoma protein inactivation'
[patent_app_type] => utility
[patent_app_number] => 15/147609
[patent_app_country] => US
[patent_app_date] => 2016-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7547
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15147609
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/147609 | Method for preventing neoplastic transformation by inhibition of retinoblastoma protein inactivation | May 4, 2016 | Issued |
Array
(
[id] => 16785002
[patent_doc_number] => 10987401
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Adiponectin peptidomimetics for treating ocular disorders
[patent_app_type] => utility
[patent_app_number] => 15/571039
[patent_app_country] => US
[patent_app_date] => 2016-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19780
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15571039
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/571039 | Adiponectin peptidomimetics for treating ocular disorders | Apr 28, 2016 | Issued |
Array
(
[id] => 11038852
[patent_doc_number] => 20160235808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'Treatment of Hepatitis C Virus Infection with Alisporivir'
[patent_app_type] => utility
[patent_app_number] => 15/140607
[patent_app_country] => US
[patent_app_date] => 2016-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7127
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15140607
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/140607 | Treatment of Hepatitis C Virus Infection with Alisporivir | Apr 27, 2016 | Abandoned |
Array
(
[id] => 14227341
[patent_doc_number] => 20190125843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => Use of antiplatelet thrombolysin in the preparation of medicine for treating thrombotic thrombocytopenic purpura
[patent_app_type] => utility
[patent_app_number] => 16/095607
[patent_app_country] => US
[patent_app_date] => 2016-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095607
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095607 | Use of antiplatelet thrombolysin in the preparation of medicine for treating thrombotic thrombocytopenic purpura | Apr 21, 2016 | Abandoned |
Array
(
[id] => 11106224
[patent_doc_number] => 20160303194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'Compositions And Method For Treatment Of Inflammatory Bowel Disease'
[patent_app_type] => utility
[patent_app_number] => 15/135060
[patent_app_country] => US
[patent_app_date] => 2016-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12658
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15135060
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/135060 | Compositions and method for treatment of inflammatory bowel disease | Apr 20, 2016 | Issued |
Array
(
[id] => 12606624
[patent_doc_number] => 20180094038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => ACYLATED GLUCAGON ANALOGUE
[patent_app_type] => utility
[patent_app_number] => 15/566338
[patent_app_country] => US
[patent_app_date] => 2016-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15566338
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/566338 | Acylated glucagon analogue | Apr 14, 2016 | Issued |